News & Analysis on Clinical Trial Services & Contract Research And Development
A filing with the SEC says that Roche is not prepared to continue in a relationship with Genentech in which it owns a majority of the biotech’s equity but has limited involvement in its governance.
Charles River Laboratories will reduce its workforce by 3 per cent, close its preclinical facility in Arkansas, US and sell off its Phase I trial site in Edinburgh, Scotland as part of a cost reduction programme.
New Sanofi Aventis chief Christopher Viebacher has virtually ruled out major acquisitions, eschewing the trend started by Pfizer’s $68bn (€53bn) swoop for Wyeth in favour of an anti-mega merger stance like that adopted by UK rival GSK.
Norwich Pharmaceuticals is expanding beyond its core business to offer clients help throughout a product’s lifecycle, covering exploring new product categories to replacing inefficient suppliers.
TGaS Advisors has launched a new version of its commercial compliance benchmark (CCB), which aims to help companies adhere to the array of guidance affecting their operations.
Spanish drug regulators have ordered a temporary halt to use of a single batch of Merck & Co’s cervical cancer vaccine Gardasil after two girls became sick after receiving the injection, according to Reuters.
An inspection system for sealing caps developed by Germany’s Vitronic could make the need for rotating pharmaceutical bottles and ampoules on the production line a thing of the past.